Home
>
National Drug Code (NDC)
>
stavudine
stavudine - 53104-0111-5 - (stavudine)
Drug Information of stavudine
| Product NDC: | 53104-0111 |
| Proprietary Name: | stavudine |
| Non Proprietary Name: | stavudine |
| Active Ingredient(s): | 1 mg/mL & nbsp; stavudine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of stavudine
| Product NDC: | 53104-0111 |
| Labeler Name: | Cipla Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078030 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090320 |
Package Information of stavudine
| Package NDC: | 53104-0111-5 |
| Package Description: | 200 mL in 1 BOTTLE (53104-0111-5) |
NDC Information of stavudine
| NDC Code | 53104-0111-5 |
| Proprietary Name | stavudine |
| Package Description | 200 mL in 1 BOTTLE (53104-0111-5) |
| Product NDC | 53104-0111 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | stavudine |
| Dosage Form Name | FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20090320 |
| Marketing Category Name | ANDA |
| Labeler Name | Cipla Limited |
| Substance Name | STAVUDINE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
